Erste Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Buy
31,219
+6,599
+27% +$544K 0.02% 342
2025
Q4
$2.14M Buy
24,620
+3,100
+14% +$254K 0.02% 345
2025
Q3
$1.66M Sell
21,520
-22,016
-51% -$1.72M 0.02% 362
2025
Q2
$3.39M Buy
43,536
+23,716
+120% +$1.77M 0.03% 322
2025
Q1
$1.41M Buy
19,820
+326
+2% +$23.3K 0.02% 345
2024
Q4
$1.47M Hold
19,494
0.02% 352
2024
Q3
$1.3M Sell
19,494
-145,848
-88% -$10.6M 0.02% 363
2024
Q2
$15.3M Sell
165,342
-26,961
-14% -$2.39M 0.2% 122
2024
Q1
$18.4M Hold
192,303
0.25% 101
2023
Q4
$14.7M Buy
192,303
+20,360
+12% +$1.42M 0.22% 119
2023
Q3
$12M Buy
171,943
+52,679
+44% +$4.23M 0.21% 123
2023
Q2
$11M Buy
119,264
+66,878
+128% +$5.81M 0.19% 133
2023
Q1
$4.27M Buy
52,386
+2,100
+4% +$165K 0.08% 227
2022
Q4
$3.78M Sell
50,286
-97,802
-66% -$7.54M 0.08% 231
2022
Q3
$12.4M Buy
148,088
+6,600
+5% +$635K 0.28% 102
2022
Q2
$13.6M Buy
141,488
+1,408
+1% +$146K 0.3% 93
2022
Q1
$16.4M Sell
140,080
-4,180
-3% -$469K 0.31% 87
2021
Q4
$18.8M Sell
144,260
-49,390
-26% -$5.76M 0.34% 86
2021
Q3
$22M Buy
193,650
+38,470
+25% +$4.39M 0.44% 71
2021
Q2
$16.1M Sell
155,180
-600
-0.4% -$56.6K 0.32% 88
2021
Q1
$12.9M Sell
155,780
-42,750
-22% -$3.61M 0.32% 96
2020
Q4
$17.9M Buy
198,530
+2,700
+1% +$224K 0.49% 57
2020
Q3
$15.3M Buy
195,830
+27,200
+16% +$2.12M 0.52% 62
2020
Q2
$11.4M Buy
168,630
+31,260
+23% +$2.22M 0.46% 60
2020
Q1
$8.98M Sell
137,370
-1,200
-0.9% -$86.5K 0.52% 55
2019
Q4
$10.8M Buy
138,570
+9,000
+7% +$703K 0.48% 55
2019
Q3
$9.38M Sell
129,570
-14,100
-10% -$990K 0.5% 53
2019
Q2
$8.88M Buy
143,670
+26,100
+22% +$1.58M 0.47% 55
2019
Q1
$7.4M Sell
117,570
-1,830
-2% -$104K 0.41% 56
2018
Q4
$5.97M Buy
+119,400
New +$6.04M 0.4% 58

Other funds holding EW